Concurrent Session

Concurrent Group III

The concurrent sessions cover topics from across the spectrum of stem cell research. Each session, framed by a brief topic overview, includes one or two invited speakers whose work highlights leading research in the field. The session is rounded out with four or more abstract-selected speakers who, combined with the invited talks, give an excellent snapshot of the most current work on the topic. The five concurrent sessions run in parallel and attendees are encouraged to move between sessions to hear talks of interest. Concurrent sessions are held Thursday, Friday, and Saturday afternoons.

Concurrent IIIA: Organoids in Modeling Disease and Development

13:15 - 15:15

Sponsored By: Decibel Therapeutics 


Arnold R. Kriegstein

University of California San Francisco, CA, United States

Dr. Kriegstein received a BS from Yale University (1971), and MD and PhD from New York University (1977). He completed Neurology Residency at the Brigham and Women’s, Children’s, and Beth Israel Hospitals, Boston, and is a board-certified clinical neurologist. He has held academic appointments at Stanford, Yale, and Columbia before joining UCSF in 2004. Dr. Kriegstein is currently the John Bowes Distinguished Professor in Stem Cell and Tissue Biology and Founding Director of the Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research at UCSF. He was elected a member of the National Academy of Medicine in 2008. Dr. Kriegstein’s research focuses on the stem cell niche and ways neural stem and progenitor cells produce neurons in the developing brain. He is particularly interested in human cortical development and evolution.


Send Email for Arnold Kriegstein

Jeffrey Beekman

University Medical Center Utrecht, Netherlands

Dr. J.M. Beekman became principle investigator in 2010 at the department of Pediatric Pulmonology of the University Medical Centre Utrecht, focussing on the development of personalized medicine applications using adult stem cell technologies. His lab developed the first clinical application of intestinal organoids for personalized drug screening in cystic fibrosis. This work led to successful treatments of patients, and shows how adult stem cells may transform future clinical care.


Send Email for Jeffrey Beekman

Jianping Fu

University of Michigan, Ann Arbor, MI, United States


Send Email for Jianping Fu

Send Email for Max Salick

Alexander Combes

University of Melbourne, VIC, Australia


Send Email for Alexander Combes

Send Email for Jorik van Rijn

Alysson Muotri

University of California, San Diego, CA, United States

Dr. Muotri is a Professor at the UCSD in departments of Pediatrics and Cellular & Molecular Medicine and Director of the Stem Cell Program. His research focuses on modeling neurological diseases using human pluripotent stem cells, using cultured human neurons, glia and organoids. He has received several awards, including the prestigious NIH Director’s New Innovator, NARSAD, Rock Star of Innovation, NIH EUREKA among others.


Send Email for Alysson Muotri


Concurrent IIIA: Organoids in Modeling Disease and Development

Attendees who have favorited this

Please enter your access key

The asset you are trying to access is locked. Please enter your access key to unlock.

Send Email for Concurrent IIIA: Organoids in Modeling Disease and Development